SCHEMBL7251875

SCHEMBL7251875

O=C1C(=Cc2cccc(F)c2)SC(c2cccc(Cl)c2)N1CCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.41
HTR7 P34969 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DRD2 P14416 3/20 0.38
HTR2A P28223 3/20 0.38
DRD3 P35462 3/20 0.38
DRD1 P21728 2/20 0.38
DRD5 P21918 1/20 0.38
ADRA2C P18825 1/20 0.38
DRD4 P21917 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7251873 1.00 HTR1A (0.41) HTR1AHTR7L3MBTL1MEN1ALDH1A1
SCHEMBL7248632 0.98 HTR1A (0.41) HTR1AHTR7L3MBTL1MEN1ALDH1A1
SCHEMBL7248634 0.98 HTR1A (0.41) HTR1AHTR7L3MBTL1MEN1ALDH1A1
SCHEMBL7250608 0.95 HTR1A (0.44) HTR1AHTR7DRD3PDE4BPDE4D
SCHEMBL7250605 0.95 HTR1A (0.44) HTR1AHTR7DRD3PDE4BPDE4D
SCHEMBL7254175 0.92 HTR7 (0.46) HTR1AHTR7ALDH1A1DRD2HTR2A
SCHEMBL7254177 0.92 HTR7 (0.46) HTR1AHTR7ALDH1A1DRD2HTR2A
SCHEMBL7247649 0.92 HTR1A (0.42) HTR1AHTR7DRD3PDE4BPDE4D
SCHEMBL7247646 0.92 HTR1A (0.42) HTR1AHTR7DRD3PDE4BPDE4D
SCHEMBL7254595 0.90 HTR7 (0.40) HTR1AHTR7DRD2DRD3DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US claimed